Mark Eisner

Company: Sonoma Biotherapeutics

Job title: Chief Medical Officer

Seminars:

Engineering Treg Approaches to Promote Immune Tolerance in Autoimmune Disease 8:30 am

Using CAR-Treg cell therapy approaches for autoimmune diseases including rheumatoid arthritis Translational data supporting 7101 CAR Treg as a therapeutic approach Demonstrating proof-of-mechanism for the immune tolerance strategyRead more

day: Conference Day Two